YC-1 Prevents Neovascular Growth in a Mouse Model of Retinopathy
Author Information
Author(s): DeNiro Michael, Al-Mohanna Falah H., Al-Mohanna Futwan A.
Primary Institution: King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
Hypothesis
Can YC-1 modulate PDGF-B and GFAP expression to influence reactive gliosis and neovascularization in retinopathy?
Conclusion
YC-1 effectively reduces reactive gliosis and neovascularization in a mouse model of oxygen-induced retinopathy.
Supporting Evidence
- YC-1 treatment reduced GFAP and PDGF-B expression significantly in both in vivo and in vitro models.
- Dual-intravitreal injections of YC-1 suppressed neovascular sprout development in the OIR mouse model.
- YC-1 downregulated hypoxia-induced overexpression of GFAP and PDGF-B in retinal cells.
Takeaway
This study shows that a drug called YC-1 can help stop the growth of new blood vessels in the eyes of mice, which can help prevent blindness.
Methodology
The study used in vivo and in vitro assays to evaluate the effects of YC-1 on reactive gliosis and neovascularization in a mouse model of oxygen-induced retinopathy.
Limitations
The study was conducted in a mouse model, which may not fully replicate human conditions.
Participant Demographics
C57BL/6J mice were used in the experiments.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website